Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.
Zhuang TZ, Goyal S, Case KB, Olsen TA, Vemuru S, Yildirim A, Goswamy RV, Brown JT, Carthon BC, Kucuk O, Bilen MA, Master VA, Nazha B. Zhuang TZ, et al. Among authors: carthon bc. J Immunother Precis Oncol. 2025 Jan 10;8(1):1-10. doi: 10.36401/JIPO-24-19. eCollection 2025 Feb. J Immunother Precis Oncol. 2025. PMID: 39811423 Free PMC article.
Characteristics, Treatment, and Outcomes of Primary Urethral Cancer: A Multicenter Review Over Two Decades.
Hopkins BD, Qian DC, Xu KM, McCook-Veal A, Switchenko J, Hartsell LM, Cimmino CB, Joshi SS, Narayan V, Master VA, Nazha B, Carthon BC, Bilen MA, Kucuk O, Shelton JW, Patel PR, Jani AB, Remick JS, Eng TY. Hopkins BD, et al. Among authors: carthon bc. Clin Genitourin Cancer. 2025 Feb;23(1):102276. doi: 10.1016/j.clgc.2024.102276. Epub 2024 Nov 28. Clin Genitourin Cancer. 2025. PMID: 39709687 No abstract available.
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial.
Bilen MA, Vo BT, Liu Y, Greenwald R, Davarpanah AH, McGuire D, Shiradkar R, Li L, Nazha B, Brown JT, Williams S, Session W, Russler G, Caulfield S, Joshi SS, Narayan VM, Filson CP, Ogan K, Kucuk O, Carthon BC, Del Balzo L, Cohen A, Boyanton A, Prokhnevska N, Cardenas MA, Sobierajska E, Jansen CS, Patil DH, Nicaise E, Osunkoya AO, Kissick H, Master VA. Bilen MA, et al. Among authors: carthon bc. Res Sq [Preprint]. 2024 Aug 8:rs.3.rs-4849400. doi: 10.21203/rs.3.rs-4849400/v1. Res Sq. 2024. PMID: 39149474 Free PMC article. Preprint.
Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual.
Hoin JA, Carthon BC, Brown SJ, Durham LM, Garrot LC, Ghamande SA, Pippas AW, Rivers BM, Snyder CT, Gabram-Mendola SGA. Hoin JA, et al. Among authors: carthon bc. Front Health Serv. 2024 Mar 8;4:1254294. doi: 10.3389/frhs.2024.1254294. eCollection 2024. Front Health Serv. 2024. PMID: 38523649 Free PMC article.
The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.
Hadadi A, Krause HB, Elliott A, Brown JT, Nazha B, Harik LR, Carthon BC, Miron B, Nabhan C, Barata PC, Saleh M, Yang Y, McKay RR, Bilen MA. Hadadi A, et al. Among authors: carthon bc. Cancers (Basel). 2023 Dec 6;15(24):5721. doi: 10.3390/cancers15245721. Cancers (Basel). 2023. PMID: 38136267 Free PMC article.
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Nazha B, Zhuang T, Wu S, Brown JT, Magee D, Carthon BC, Kucuk O, Nabhan C, Barata PC, Heath EI, Ryan CJ, McKay RR, Master VA, Bilen MA. Nazha B, et al. Among authors: carthon bc. Cancer. 2023 Dec 15;129(24):3884-3893. doi: 10.1002/cncr.34982. Epub 2023 Aug 11. Cancer. 2023. PMID: 37565840 Free article.
Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808.
Carthon BC, Kim SE, McDermott DF, Dutcher JP, Puligandla M, Manola J, Pins M, Carducci MA, Plimack ER, Appleman LJ, MacVicar GR, Kohli M, Kuzel TM, DiPaola RS, Haas NB. Carthon BC, et al. Clin Genitourin Cancer. 2023 Oct;21(5):546-554. doi: 10.1016/j.clgc.2023.06.012. Epub 2023 Jul 3. Clin Genitourin Cancer. 2023. PMID: 37455214 Free PMC article. Clinical Trial.
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
Sanda GE, Shabto JM, Goyal S, Liu Y, Martini DJ, Nazha B, Brown JT, Yantorni LB, Anne Russler G, Caulfield S, Joshi SS, Narayan VM, Kissick H, Ogan K, Master VA, Carthon BC, Kucuk O, Bilen MA. Sanda GE, et al. Among authors: carthon bc. Oncologist. 2023 Dec 11;28(12):1072-1078. doi: 10.1093/oncolo/oyad154. Oncologist. 2023. PMID: 37285524 Free PMC article.
57 results